Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Bukreyev

Showing results (111-120 of 169) with videos related to

Pageof 17
Sort By:
Plos Biology|May 20, 2026
Redundant and distinct mechanisms suppress innate immune activation during SARS-CoV-2 infectionFuchun Zhou, Sivakumar Periasamy, Nathaniel D Jackson, et al.
Communications Biology|July 17, 2024
Antibodies targeting the glycan cap of Ebola virus glycoprotein are potent inducers of the complement systemPhilipp A Ilinykh, Kai Huang, Bronwyn M Gunn, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2022
A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletionsYang Liu, Xianwen Zhang, Jianying Liu, et al.
Cell Reports|April 14, 2021
Convergence of a common solution for broad ebolavirus neutralization by glycan cap-directed human antibodiesCharles D Murin, Pavlo Gilchuk, Philipp A Ilinykh, et al.
Cell|February 28, 2015
Mechanism of human antibody-mediated neutralization of Marburg virusAndrew I Flyak, Philipp A Ilinykh, Charles D Murin, et al.
Biorxiv : the Preprint Server for Biology|June 8, 2021
Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blockingAndrea R Shiakolas, Nicole Johnson, Kevin J Kramer, et al.
Cell Reports|May 5, 2021
Broad and potently neutralizing monoclonal antibodies isolated from human survivors of New World hantavirus infectionTaylor B Engdahl, Natalia A Kuzmina, Adam J Ronk, et al.
Nature Communications|July 27, 2022
A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletionsYang Liu, Xianwen Zhang, Jianying Liu, et al.
Nature Biotechnology|March 4, 2022
Efficient discovery of SARS-CoV-2-neutralizing antibodies via B cell receptor sequencing and ligand blockingAndrea R Shiakolas, Kevin J Kramer, Nicole V Johnson, et al.
Frontiers in Immunology|August 2, 2021
Proteo-Genomic Analysis Identifies Two Major Sites of Vulnerability on Ebolavirus Glycoprotein for Neutralizing Antibodies in Convalescent Human PlasmaPavlo Gilchuk, Adrian Guthals, Stefano R Bonissone, et al.
Pageof 17

Showing results (111-120 of 169) with videos related to

Sort By:
Pageof 17
Plos Biology|May 20, 2026
Redundant and distinct mechanisms suppress innate immune activation during SARS-CoV-2 infectionFuchun Zhou, Sivakumar Periasamy, Nathaniel D Jackson, et al.
Communications Biology|July 17, 2024
Antibodies targeting the glycan cap of Ebola virus glycoprotein are potent inducers of the complement systemPhilipp A Ilinykh, Kai Huang, Bronwyn M Gunn, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2022
A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletionsYang Liu, Xianwen Zhang, Jianying Liu, et al.
Cell Reports|April 14, 2021
Convergence of a common solution for broad ebolavirus neutralization by glycan cap-directed human antibodiesCharles D Murin, Pavlo Gilchuk, Philipp A Ilinykh, et al.
Cell|February 28, 2015
Mechanism of human antibody-mediated neutralization of Marburg virusAndrew I Flyak, Philipp A Ilinykh, Charles D Murin, et al.
Biorxiv : the Preprint Server for Biology|June 8, 2021
Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blockingAndrea R Shiakolas, Nicole Johnson, Kevin J Kramer, et al.
Cell Reports|May 5, 2021
Broad and potently neutralizing monoclonal antibodies isolated from human survivors of New World hantavirus infectionTaylor B Engdahl, Natalia A Kuzmina, Adam J Ronk, et al.
Nature Communications|July 27, 2022
A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletionsYang Liu, Xianwen Zhang, Jianying Liu, et al.
Nature Biotechnology|March 4, 2022
Efficient discovery of SARS-CoV-2-neutralizing antibodies via B cell receptor sequencing and ligand blockingAndrea R Shiakolas, Kevin J Kramer, Nicole V Johnson, et al.
Frontiers in Immunology|August 2, 2021
Proteo-Genomic Analysis Identifies Two Major Sites of Vulnerability on Ebolavirus Glycoprotein for Neutralizing Antibodies in Convalescent Human PlasmaPavlo Gilchuk, Adrian Guthals, Stefano R Bonissone, et al.
Pageof 17